ATP13A2 Antikörper (Internal Region)
-
- Target Alle ATP13A2 Antikörper anzeigen
- ATP13A2 (ATPase Type 13A2 (ATP13A2))
-
Bindungsspezifität
- AA 200-300, Internal Region
-
Reaktivität
- Human, Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser ATP13A2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC)
- Spezifität
- Reacts with human and mouse ~129 kDa ATP13A2 protein
- Aufreinigung
- Antigen affinity purified
- Immunogen
- Synthetic peptide within the internal region of residues 200-300 of the human ATP13A2 protein
- Top Product
- Discover our top product ATP13A2 Primärantikörper
-
-
- Applikationshinweise
-
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only:
- IHC : 10 to 20 μg/mL - WB : 2 μg/mL - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.75 mg/mL
- Buffer
- Tris-glycine, NaCl 150 mM buffer, Sodium azide 0.05 %
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C/-80 °C
- Informationen zur Lagerung
- Aliquot and store at -20°C or -80°C. Avoid freeze-thaw cycles.
-
- Target
- ATP13A2 (ATPase Type 13A2 (ATP13A2))
- Andere Bezeichnung
- Probable Cation-Transporting ATPase 13A2 (ATP13A2 Produkte)
- Synonyme
- ATP13A2 antikoerper, 1110012E06Rik antikoerper, AA589443 antikoerper, RGD1307977 antikoerper, im:7147302 antikoerper, zgc:136762 antikoerper, CLN12 antikoerper, HSA9947 antikoerper, KRPPD antikoerper, PARK9 antikoerper, ATPase 13A2 antikoerper, ATPase type 13A2 antikoerper, probable cation-transporting ATPase 13A2 antikoerper, ATP13A2 antikoerper, Atp13a2 antikoerper, atp13a2 antikoerper, PTRG_01071 antikoerper, MCYG_01937 antikoerper, LOC100439053 antikoerper
- Pathways
- Ribonucleoside Biosynthetic Process
-